Oncolytics Biotech
Price & Volume
Stats
See more52W Range | $0.77-$1.51 |
Market Cap | $107.8M |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.32 |
News
See moreYahoo Finance • 30 days ago
Oncolytics' New U.S Patent Extends Pelareorep Manufacturing Protection Into 2044
Yahoo Finance • last month
Sector Update: Healthcare Stocks Advance in Afternoon Trading
Yahoo Finance • last month
Oncolytics Biotech® Announces Appointment of Steve Glover to Board of Directors and Promotion of John McAdory to Chief Operating Officer
Yahoo Finance • 2 months ago
"Cold" Solid Tumors Become the Proving Ground for a New Generation of Engager and Immune-Priming Therapies
About
CEO | Mr. Jared Kelly J.D., L.L.M. |
Address | 4350 Executive Drive, San Diego, CA, United States, 92121 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 29 |